Erhan Akdoğan – President, Turkish Health Institutes…
The president of the Turkish Health Institutes (TUSEB), Dr Erhan Akdoğan, provides a behind-the-scenes look at the development process of Turkovac,…
Tagged with Coronavirus
3 Pfizer Country Managers on COVID-19 Vaccine Rollout &…
The global push to vaccinate populations against COVID-19 has played out differently in different geographies, with a yawning gap still existing…
Enough COVID Vaccines for World Population Says IFPMA: Calls for…
Pharma industry leaders have called for rich nations to stop stockpiling excess COVID-19 vaccine doses and stated that there will be enough production…
Spain Enters the COVID-19 Vaccine Race Through Animal Health…
The Spanish pharma industry has entered the race to develop COVID-19 vaccines through an unexpected contender: an animal health company. HIPRA,…
Marco Lee – Vice-President & General Manager, APAC,…
Marco Lee, APAC head for medical device firm Avanos explains how the company's products are catered to patient needs in the region and talks through…
Vinod Narayanan – Country President, AstraZeneca Singapore
AstraZeneca (AZ)’s country president for Singapore, Vinod Narayanan, outlines the challenges of taking the reins at an affiliate against the…
The COVID-19 Pandemic in Japan: Treatments, Vaccines &…
Writing in the August edition of DIA’s Global Forum, Kotone Matsuyama of the Nippon Medical School gives a run-through of Japan's response to the…
Africa’s Biggest Pharma Company Gets $700 million for Vaccine…
With Africa struggling to vaccinate its populations against COVID-19, the World Bank – along with government institutions from the USA, Germany, and…
Brazil Pharma News: EMS Sales Soar; Irregularities in Indian…
The latest news from Brazilian pharma, including an investigation into the country’s deal with Indian lab Bharat Biotech to purchase COVID-19…
Mexico Pharma News: Bayer Targets Cancer; Novartis Gets…
The latest news from Mexican pharma, including Bayer’s big bet on oncology and Novartis’ aggressive expansion strategy as well as updates on the…
Health & Patent Rights During the COVID-19 Pandemic
There is no doubt that COVID-19 has impacted almost every aspect of our lives. Due to the ongoing health crisis, among other efforts, governments have…
Germany Pharma News: Merck KGaA Expecting More COVID-Related…
The latest news from German pharma, including a new US leadership team and more COVID-related investment at Merck KGaA; the CureVac vaccine’s role…
